Assertio

Search

Overview

Recent News

Date	Title and Summary
Toggle Summary Nov 05, 1997	DepoMed, Inc. Announces Initial Public Offering FOSTER CITY, CA - November 5, 1997 -- DepoMed, Inc. today announced its initial public offering of 1,200,000 Units (each Unit consisting of one share of common stock and one common stock purchase warrant), at a price of $6.10 per Unit. The Units are quoted on the Nasdaq Small Cap Market under the
Toggle Summary Dec 01, 1997	DepoMed, Inc. Announces Separation of Units FOSTER CITY, CA - December 1, 1997 - DepoMed, Inc. (Nasdaq: DPMDU) today announced that, effective December 1, 1997, the Common Stock and Warrants comprising the Company's Units will become detachable and separately transferable. Also effective as of December 1, 1997, the shares of Common Stock and
Toggle Summary Feb 12, 1998	DR. W. Leigh Thompson Joins Depomed's Board FOSTER CITY, CA - February 12, 1998 - DepoMed, Inc. today announced that Dr. W. Leigh Thompson was elected to the Board of Directors on January 30, 1998. Dr. Thompson (59) was previously Chief Scientific Officer at Eli Lilly before founding Profound Quality Resources, Ltd., a private healthcare

Recent SEC Filings

Filing date	Description	Form	Filing Group	View
Aug 07, 2020	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001808665-20-000030.pdf 0001808665-20-000030.rtf 0001808665-20-000030.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 23, 2020	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001104659-20-076113.pdf 0001104659-20-076113.rtf 0001104659-20-076113.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 18, 2020	Termination of registration under Section 12(g) or suspension of duty to file reports	15-12B	Other	View HTML 0001104659-20-074525.pdf 0001104659-20-074525.rtf 0001104659-20-074525.xls
Jun 04, 2020	Securities offered to employees pursuant to employee benefit plans	S-8	Registration Statements	View HTML 0001104659-20-069548.pdf 0001104659-20-069548.rtf 0001104659-20-069548.xls
Jun 04, 2020	Securities offered to employees pursuant to employee benefit plans	S-8	Registration Statements	View HTML 0001104659-20-069549.pdf 0001104659-20-069549.rtf 0001104659-20-069549.xls

IR Contact

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com

Independent Registered Public Accounting Firm

Ernst & Young LLP
Palo Alto, CA

Investor Relations Contact

investor@assertiotx.com